Melatonin Effects on Plasmodium Life Cycle: New Avenues for Therapeutic Approach

被引:7
|
作者
Srinivasan, Venkataramanujam [1 ]
Ahmad, Asma H. [2 ]
Mohamed, Mahaneem [2 ]
Zakaria, Rahimah [2 ]
机构
[1] Sri Sathya Sai Med Educ & Res Fdn, Med Sci Res Study Ctr, 40-Kovai Thirunagar, Coimbatore 641014, Tamil Nadu, India
[2] Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Kubang Kerian 16150, Kelantan, Malaysia
关键词
Anti-malarial drugs; bright light therapy; luzindole; malaria; melatonin; Plasmodium falciparum;
D O I
10.2174/187221412800604635
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Malaria remains a global health problem affecting more than 515 million people all over the world including Malaysia. It is on the rise, even within unknown regions that previous to this were free of malaria. Although malaria eradication programs carried out by vector control programs are still effective, anti-malarial drugs are also used extensively for curtailing this disease. But resistance to the use of anti-malarial drugs is also increasing on a daily basis. With an increased understanding of mechanisms that cause growth, differentiation and development of malarial parasites in rodents and humans, new avenues of therapeutic approaches for controlling the growth, synchronization and development of malarial parasites are essential. Within this context, the recent discoveries related to IP3 interconnected signalling pathways, the release of Ca2+ from intracellular stores of Plasmodium, ubiquitin protease systems as a signalling pathway, and melatonin influencing the growth and differentiation of malarial parasites by its effects on these signalling pathways have opened new therapeutic avenues for arresting the growth and differentiation of malarial parasites. Indeed, the use of melatonin antagonist, luzindole, has inhibited the melatonin's effect on these signalling pathways and thereby has effectively reduced the growth and differentiation of malarial parasites. As Plasmodium has effective sensors which detect the nocturnal plasma melatonin concentrations, suppression of plasma melatonin levels with the use of bright light during the night or by anti-melatonergic drugs and by using anti-kinase drugs will help in eradicating malaria on a global level. A number of patients have been admitted with regards to the control and management of malarial growth. Patents related to the discovery of serpentine receptors on Plasmodium, essential for modulating intra parasitic melatonin levels, procedures for effective delivery of bright light to suppress plasma melatonin levels and thereby arresting the growth and elimination of malarial parasites from the blood of the host are all cited in the paper. The purpose of the paper is to highlight the importance of melatonin acting as a cue for Plasmodium faciparum growth and to discuss the ways of curbing the effects of melatonin on Plasmodium growth and for arresting its life cycle, as a method of eliminating the parasite from the host.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [1] A metabolic perspective of the neutrophil life cycle: new avenues in immunometabolism
    Thind, Mehakpreet K.
    Uhlig, Holm H.
    Glogauer, Michael
    Palaniyar, Nades
    Bourdon, Celine
    Gwela, Agnes
    Lancioni, Christina L.
    Berkley, James A.
    Bandsma, Robert H. J.
    Farooqui, Amber
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [2] Diverse Effects of Statins on Angiogenesis: New Therapeutic Avenues
    Elewa, Hazem F.
    El-Remessy, Azza B.
    Somanath, Payaningal R.
    Fagan, Susan C.
    PHARMACOTHERAPY, 2010, 30 (02): : 169 - 176
  • [3] New therapeutic avenues in SLE
    Bakshi, Jyoti
    Ismajli, Mediola
    Rahman, Anisur
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2015, 29 (06): : 794 - 809
  • [4] New therapeutic avenues in autoimmunity
    Amital, H
    Swissa, M
    BarDayan, Y
    Buskila, D
    Shoenfeld, Y
    RESEARCH IN IMMUNOLOGY, 1996, 147 (06): : 361 - 376
  • [5] Correction to: Melatonin and urological cancers: a new therapeutic approach
    Mohammad Hossein Pourhanifeh
    Azam Hosseinzadeh
    Kobra Bahrampour Juybari
    Saeed Mehrzadi
    Cancer Cell International, 20
  • [6] New therapeutic avenues in glaucoma surgery
    Henein, Christin
    Lee, Richard M. H.
    Khaw, Peng T.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2018, 13 (05) : 253 - 255
  • [7] New diagnostic and therapeutic avenues for mesothelioma
    Paraeha, Usman Zafar
    Hayat, Khezar
    Ali, Muhammad
    Qadir, Muhammad Imran
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (04) : 1425 - 1432
  • [8] New therapeutic avenues for Duchenne muscular dystrophy
    Kirschner, Janbernd
    LANCET NEUROLOGY, 2024, 23 (04): : 330 - 331
  • [9] Diabetes and vascular disease: New therapeutic avenues
    Del Prato, Stefano
    VASCULAR PHARMACOLOGY, 2024, 154
  • [10] Cancer "Clock" Opens New Therapeutic Avenues
    Dolgin, Elie
    CANCER DISCOVERY, 2017, 7 (12) : 1358 - 1358